Impact on diabetes control and patient-reported outcomes of a newer implantable continuous glucose monitoring system (Eversense® CGM System): a single-centre retro- and prospective observational study. (2024). Swiss Medical Weekly, 154(3), 3366. https://doi.org/10.57187/s.3366